High-quality products
Reliable performance
Glucose-dependent insulinotropic polypeptide (GIP) and glucagonlike peptide-1 are gut-derived incretin hormones, it can augment glucose-stimulated insulin secretion and also to promote satiety. GIPR has been identified in genome-wide association studies (GWAS) of body mass index (BMI) measurements. It can develop a therapeutic GIPR antagonist for the treatment of obesity.
High-quality products
Reliable performance
Wide range of applications
For various laboratory needs
Expert support
Professional service team
Fast delivery
Global shipping